[MDGL] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -31.76%
YoY- -1.78%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -19,699 -15,080 -11,475 -8,512 -6,460 -6,364 -8,445 76.15%
Tax 0 0 -25 0 -1,166 0 -276 -
NP -19,699 -15,080 -11,475 -8,512 -6,460 -6,364 -8,445 76.15%
Tax Rate - - - - - - - -
Total Cost 19,699 15,080 11,475 8,512 6,460 6,364 8,445 76.15%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -1.28 -0.98 -0.75 -0.56 -0.45 -0.45 -0.67 54.14%
EPS Diluted -1.28 -0.98 -0.75 -0.56 -0.45 -0.45 -0.67 54.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.